The Centre brings together AstraZeneca, one of the leading global biopharmaceutical businesses, which has expertise in drug discovery and development, and the University of Glasgow, which has an international reputation in the area of infection, inflammation and immunology and excels in linking basic science to our understanding of disease pathology.
University of Glasgow
Institute of Infection, Immunity and Inflammation
Basic, applied, clinical and translational research
Infectious, autoimmune and inflammatory diseases place an enormous global burden on human and animal health. The Institute of Infection, Immunity and Inflammation comprises scientists and clinicians working together to promote and develop research, drug discovery and ultimately improvements in patient care in this area of critical international importance.
To achieve this, our aims are ambitious.
- To understand the basic science of the immune system and how the immune system can in turn promote disease
- To understand the biology of parasites, viruses and bacteria and the interactions with their hosts, that in turn leads to high levels of infectious disease worldwide
- To develop therapies (drugs and vaccines) targeted on these processes
- To explore new treatments and strategies in clinical and translational medicine
Our research expertise to meet these challenges?
The Institute contains scientists and clinical investigators of global repute who possess the broad expertise necessary to achieve our aims. Thus our principal investigators include geneticists, molecular and cell biologists, biochemists, immunologists, bacteriologists, virologists, parasitologists, pathologists and clinical investigators. This expertise is supported by state of the art basic science technology, integrated seamlessly with translational clinical trial facilities – we aspire to a truly ‘bench to bedside and back’ approach to resolving crucial questions of this new millennium.
About our research and development
Our mission is to make a meaningful difference to healthcare through great medicines. This is founded on the pursuit of scientific excellence that addresses unmet patient need.
Our expertise spans the entire life-cycle of a medicine and we have capabilities in both small molecules and biologics. This allows us to search for solutions to unmet medical needs using both modalities, individually or in combination.